TRIDENT LIFELINE
Back to Cashflow Statement
|
TRIDENT LIFELINE Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-4.31 Cr | ₹-7.13 Cr | ₹14 Cr | ₹0.14 Cr |
What is the latest Net Cash Inflow / Outflow ratio of TRIDENT LIFELINE ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-4.31 Cr |
| Mar2024 | ₹-7.13 Cr |
| Mar2023 | ₹14 Cr |
| Mar2022 | ₹0.14 Cr |
How is Net Cash Inflow / Outflow of TRIDENT LIFELINE Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-4.31 Cr | Negative | |
| Mar2024 | ₹-7.13 Cr | Negative | |
| Mar2023 | ₹14 Cr | 9,474.65 | |
| Mar2022 | ₹0.14 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹324.3 Cr | -2.6% | 3.1% | 0.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | -2.6% |
3.1% |
0.7% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses